Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance

Published:2012-06 Issue:6 Volume:23 Page:1617-1626
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

van Oosterwijk J.G.,Herpers B.,Meijer D.,Briaire-de Bruijn I.H.,Cleton-Jansen A.M.,Gelderblom H.,van de Water B.,Bovée J.V.M.G.

Funder

The Netherlands Organization for Scientific Research

Dutch Cancer Society

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/6/1617/13785837/mdr512.pdf

Reference43 articles.

1. Chondrosarcoma;Bertoni,2002

2. Risk factors for survival and local control in chondrosarcoma of bone;Fiorenza;J Bone Joint Surg Br,2002

3. The clinical approach towards chondrosarcoma;Gelderblom;Oncologist,2008

4. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment;Bovee;Lancet Oncol,2005

5. Cartilage tumours and bone development: molecular pathology and possible therapeutic targets;Bovee;Nat Rev Cancer,2010

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KDELR1 regulates chondrosarcoma drug resistance and malignant behavior through Intergrin-Hippo-YAP1 axis;2024-08-29

2. Chondrosarcoma of the Mobile Spine in the Elderly: A National Cancer Database Study;World Neurosurgery;2024-07

3. Combined Application of Cold Physical Plasma and Chemotherapeutics against Chondrosarcoma Cells;International Journal of Molecular Sciences;2024-06-25

4. New advances in the treatment of chondrosarcoma under the PD-1/PD-L1 pathway;Journal of Cancer Research and Therapeutics;2024-04

5. Development of Injectable Thermosensitive Nanocomposite Hydrogel for Ratiometric Drug Delivery to Treat Drug Resistant Chondrosarcoma In Vivo;Small;2024-03-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3